Phase 1 Study of Allo-RevCAR01-T-CD123 in Patients With Selected CD123 Positive Hematologic Malignancies

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2022-501797-19-00

Acronym

AVC-201-01

Enrollment

Registered

2023-06-16

Start date

2023-07-13

Completion date

Unknown

Last updated

2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myeloid Leukemia (AML)

None listed

Sex/Gender

All

Age

18 Years to No maximum

Germany, Netherlands

None listed

Source: EU CTIS · Data processed: Feb 4, 2026